nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxtriphylline—HDAC2—Lovastatin—atherosclerosis	0.657	0.8	CbGbCtD
Oxtriphylline—SLC22A7—Pravastatin—atherosclerosis	0.164	0.2	CbGbCtD
Oxtriphylline—PDE3A—penis—atherosclerosis	0.00837	0.22	CbGeAlD
Oxtriphylline—PDE3B—connective tissue—atherosclerosis	0.00253	0.0667	CbGeAlD
Oxtriphylline—PDE3B—cardiovascular system—atherosclerosis	0.0022	0.058	CbGeAlD
Oxtriphylline—PDE3B—adipose tissue—atherosclerosis	0.00194	0.0511	CbGeAlD
Oxtriphylline—HDAC2—Lovastatin—Simvastatin—atherosclerosis	0.00163	0.222	CbGdCrCtD
Oxtriphylline—HDAC2—Lovastatin—Pravastatin—atherosclerosis	0.00163	0.222	CbGdCrCtD
Oxtriphylline—PDE4D—adipose tissue—atherosclerosis	0.00162	0.0427	CbGeAlD
Oxtriphylline—ADORA2B—adipose tissue—atherosclerosis	0.00161	0.0424	CbGeAlD
Oxtriphylline—ADORA2A—cardiovascular system—atherosclerosis	0.00152	0.04	CbGeAlD
Oxtriphylline—HDAC2—connective tissue—atherosclerosis	0.00149	0.0392	CbGeAlD
Oxtriphylline—PDE4A—adipose tissue—atherosclerosis	0.00144	0.0378	CbGeAlD
Oxtriphylline—HDAC2—Fluvastatin—Rosuvastatin—atherosclerosis	0.0014	0.191	CbGdCrCtD
Oxtriphylline—PDE3B—liver—atherosclerosis	0.00136	0.0359	CbGeAlD
Oxtriphylline—PDE3A—cardiovascular system—atherosclerosis	0.00135	0.0354	CbGeAlD
Oxtriphylline—HDAC2—Simvastatin—Pravastatin—atherosclerosis	0.00133	0.182	CbGdCrCtD
Oxtriphylline—HDAC2—Simvastatin—Lovastatin—atherosclerosis	0.00133	0.182	CbGdCrCtD
Oxtriphylline—ADORA1—cardiovascular system—atherosclerosis	0.00131	0.0345	CbGeAlD
Oxtriphylline—HDAC2—cardiovascular system—atherosclerosis	0.0013	0.0341	CbGeAlD
Oxtriphylline—PDE3A—adipose tissue—atherosclerosis	0.00119	0.0312	CbGeAlD
Oxtriphylline—ADORA1—adipose tissue—atherosclerosis	0.00116	0.0304	CbGeAlD
Oxtriphylline—HDAC2—adipose tissue—atherosclerosis	0.00114	0.0301	CbGeAlD
Oxtriphylline—PDE4D—liver—atherosclerosis	0.00114	0.0299	CbGeAlD
Oxtriphylline—ADORA2A—liver—atherosclerosis	0.00094	0.0247	CbGeAlD
Oxtriphylline—SLC22A7—liver—atherosclerosis	0.000932	0.0245	CbGeAlD
Oxtriphylline—PDE4B—adipose tissue—atherosclerosis	0.000856	0.0225	CbGeAlD
Oxtriphylline—PDE3A—liver—atherosclerosis	0.000833	0.0219	CbGeAlD
Oxtriphylline—HDAC2—liver—atherosclerosis	0.000802	0.0211	CbGeAlD
Oxtriphylline—PDE4B—liver—atherosclerosis	0.0006	0.0158	CbGeAlD
Oxtriphylline—CYP1A2—liver—atherosclerosis	0.000369	0.0097	CbGeAlD
Oxtriphylline—PDE4B—Signaling Pathways—PIK3CG—atherosclerosis	2.01e-05	0.00015	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—NOS3—atherosclerosis	2e-05	0.000149	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—INS—atherosclerosis	2e-05	0.000149	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—IGF1—atherosclerosis	1.99e-05	0.000148	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—NOS3—atherosclerosis	1.99e-05	0.000148	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—SERPINE1—atherosclerosis	1.98e-05	0.000148	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	1.97e-05	0.000147	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—CCL2—atherosclerosis	1.97e-05	0.000147	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—SPP1—atherosclerosis	1.97e-05	0.000147	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—CXCL8—atherosclerosis	1.96e-05	0.000146	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—PDGFB—atherosclerosis	1.96e-05	0.000146	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—MAPK3—atherosclerosis	1.95e-05	0.000145	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—IGF1—atherosclerosis	1.93e-05	0.000144	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—CXCL8—atherosclerosis	1.93e-05	0.000144	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—NOS3—atherosclerosis	1.93e-05	0.000144	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—INS—atherosclerosis	1.93e-05	0.000144	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—MAPK3—atherosclerosis	1.92e-05	0.000144	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—AGT—atherosclerosis	1.91e-05	0.000143	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—INS—atherosclerosis	1.9e-05	0.000142	CbGpPWpGaD
Oxtriphylline—HDAC2—Hemostasis—AKT1—atherosclerosis	1.9e-05	0.000142	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—NOS3—atherosclerosis	1.89e-05	0.000141	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—CCL2—atherosclerosis	1.89e-05	0.000141	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—SERPINE1—atherosclerosis	1.89e-05	0.000141	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—ABCG1—atherosclerosis	1.88e-05	0.00014	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—CCL2—atherosclerosis	1.87e-05	0.00014	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—APOE—atherosclerosis	1.87e-05	0.00014	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—LEP—atherosclerosis	1.87e-05	0.00014	CbGpPWpGaD
Oxtriphylline—PDE4C—GPCR downstream signaling—AKT1—atherosclerosis	1.86e-05	0.000139	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—IGF1—atherosclerosis	1.86e-05	0.000139	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—CAV1—atherosclerosis	1.85e-05	0.000138	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—APOA1—atherosclerosis	1.85e-05	0.000138	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—IGF1—atherosclerosis	1.84e-05	0.000137	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—SERPINE1—atherosclerosis	1.84e-05	0.000137	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling by GPCR—IL6—atherosclerosis	1.84e-05	0.000137	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—PTGS2—atherosclerosis	1.83e-05	0.000137	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—PDGFB—atherosclerosis	1.82e-05	0.000136	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—NOS3—atherosclerosis	1.8e-05	0.000135	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—ESR1—atherosclerosis	1.79e-05	0.000133	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—AGT—atherosclerosis	1.78e-05	0.000133	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—SERPINE1—atherosclerosis	1.77e-05	0.000132	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—F2—atherosclerosis	1.77e-05	0.000132	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—FABP4—atherosclerosis	1.76e-05	0.000132	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—LCAT—atherosclerosis	1.76e-05	0.000132	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—CXCL8—atherosclerosis	1.76e-05	0.000131	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—NOS3—atherosclerosis	1.75e-05	0.000131	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—SERPINE1—atherosclerosis	1.75e-05	0.00013	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—MMP9—atherosclerosis	1.75e-05	0.00013	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—LEP—atherosclerosis	1.74e-05	0.00013	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—APOE—atherosclerosis	1.74e-05	0.00013	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—APOA4—atherosclerosis	1.73e-05	0.000129	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—NFKB1—atherosclerosis	1.73e-05	0.000129	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—CAV1—atherosclerosis	1.72e-05	0.000129	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—APOA1—atherosclerosis	1.72e-05	0.000128	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—CXCL8—atherosclerosis	1.71e-05	0.000127	CbGpPWpGaD
Oxtriphylline—ADORA2B—GPCR downstream signaling—AKT1—atherosclerosis	1.7e-05	0.000127	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—CYP7A1—atherosclerosis	1.7e-05	0.000127	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—MAPK8—atherosclerosis	1.7e-05	0.000127	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling by GPCR—AKT1—atherosclerosis	1.69e-05	0.000126	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—PIK3CG—atherosclerosis	1.69e-05	0.000126	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—NOS3—atherosclerosis	1.69e-05	0.000126	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—CXCL8—atherosclerosis	1.68e-05	0.000125	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling by GPCR—IL6—atherosclerosis	1.67e-05	0.000125	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—NOS3—atherosclerosis	1.67e-05	0.000125	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—ESR1—atherosclerosis	1.66e-05	0.000124	CbGpPWpGaD
Oxtriphylline—PDE3B—GPCR downstream signaling—AKT1—atherosclerosis	1.65e-05	0.000123	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—F2—atherosclerosis	1.64e-05	0.000122	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by GPCR—IL6—atherosclerosis	1.62e-05	0.000121	CbGpPWpGaD
Oxtriphylline—PDE4D—GPCR downstream signaling—AKT1—atherosclerosis	1.62e-05	0.000121	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	1.62e-05	0.000121	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—CXCL8—atherosclerosis	1.6e-05	0.000119	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—INS—atherosclerosis	1.6e-05	0.000119	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—IL6—atherosclerosis	1.6e-05	0.000119	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—MMP9—atherosclerosis	1.59e-05	0.000119	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—NFKB1—atherosclerosis	1.58e-05	0.000118	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—CCL2—atherosclerosis	1.57e-05	0.000117	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—CYP27A1—atherosclerosis	1.57e-05	0.000117	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—PIK3CG—atherosclerosis	1.57e-05	0.000117	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—VEGFA—atherosclerosis	1.57e-05	0.000117	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—CXCL8—atherosclerosis	1.56e-05	0.000116	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—STAT3—atherosclerosis	1.55e-05	0.000116	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—MAPK8—atherosclerosis	1.55e-05	0.000116	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.55e-05	0.000115	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—IGF1—atherosclerosis	1.55e-05	0.000115	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling by GPCR—AKT1—atherosclerosis	1.55e-05	0.000115	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—MMP9—atherosclerosis	1.55e-05	0.000115	CbGpPWpGaD
Oxtriphylline—PDE4A—GPCR downstream signaling—AKT1—atherosclerosis	1.55e-05	0.000115	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—NFKB1—atherosclerosis	1.53e-05	0.000114	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—IL6—atherosclerosis	1.52e-05	0.000114	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—MMP9—atherosclerosis	1.52e-05	0.000113	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.51e-05	0.000113	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—MAPK3—atherosclerosis	1.5e-05	0.000112	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—NFKB1—atherosclerosis	1.5e-05	0.000112	CbGpPWpGaD
Oxtriphylline—PDE3A—GPCR downstream signaling—AKT1—atherosclerosis	1.5e-05	0.000112	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—MAPK8—atherosclerosis	1.5e-05	0.000112	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling by GPCR—AKT1—atherosclerosis	1.5e-05	0.000112	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—CXCL8—atherosclerosis	1.5e-05	0.000112	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—APOA2—atherosclerosis	1.49e-05	0.000111	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—ALOX15—atherosclerosis	1.49e-05	0.000111	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—PLA2G2A—atherosclerosis	1.49e-05	0.000111	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—ALOX5AP—atherosclerosis	1.49e-05	0.000111	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—INS—atherosclerosis	1.49e-05	0.000111	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—MAPK3—atherosclerosis	1.48e-05	0.000111	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—CXCL8—atherosclerosis	1.48e-05	0.00011	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—IL6—atherosclerosis	1.48e-05	0.00011	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—MAPK8—atherosclerosis	1.48e-05	0.00011	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling by GPCR—AKT1—atherosclerosis	1.47e-05	0.00011	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—ABCG5—atherosclerosis	1.47e-05	0.00011	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.47e-05	0.00011	CbGpPWpGaD
Oxtriphylline—HDAC2—Gene Expression—MAPK3—atherosclerosis	1.47e-05	0.00011	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—SERPINE1—atherosclerosis	1.47e-05	0.00011	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—CCL2—atherosclerosis	1.46e-05	0.000109	CbGpPWpGaD
Oxtriphylline—ADORA1—GPCR downstream signaling—AKT1—atherosclerosis	1.45e-05	0.000108	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—MMP9—atherosclerosis	1.45e-05	0.000108	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—TGFB1—atherosclerosis	1.44e-05	0.000107	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—IGF1—atherosclerosis	1.44e-05	0.000107	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—NFKB1—atherosclerosis	1.43e-05	0.000107	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—VEGFA—atherosclerosis	1.43e-05	0.000107	CbGpPWpGaD
Oxtriphylline—PDE4B—GPCR downstream signaling—AKT1—atherosclerosis	1.43e-05	0.000107	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—STAT3—atherosclerosis	1.43e-05	0.000107	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—IL6—atherosclerosis	1.42e-05	0.000106	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—LPA—atherosclerosis	1.42e-05	0.000106	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—STAT3—atherosclerosis	1.42e-05	0.000106	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—MMP9—atherosclerosis	1.41e-05	0.000105	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—IL6—atherosclerosis	1.41e-05	0.000105	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—MAPK8—atherosclerosis	1.41e-05	0.000105	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling by GPCR—AKT1—atherosclerosis	1.4e-05	0.000105	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—NOS3—atherosclerosis	1.4e-05	0.000105	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—NFKB1—atherosclerosis	1.39e-05	0.000104	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—VEGFA—atherosclerosis	1.39e-05	0.000104	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—BGN—atherosclerosis	1.38e-05	0.000103	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—STAT3—atherosclerosis	1.37e-05	0.000103	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—MAPK8—atherosclerosis	1.37e-05	0.000102	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.37e-05	0.000102	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—SERPINE1—atherosclerosis	1.37e-05	0.000102	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling by GPCR—AKT1—atherosclerosis	1.36e-05	0.000102	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—VEGFA—atherosclerosis	1.36e-05	0.000102	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—MAPK3—atherosclerosis	1.36e-05	0.000102	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—APOA5—atherosclerosis	1.36e-05	0.000102	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—MMP9—atherosclerosis	1.35e-05	0.000101	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—MAPK3—atherosclerosis	1.35e-05	0.000101	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—STAT3—atherosclerosis	1.35e-05	0.000101	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—NFKB1—atherosclerosis	1.34e-05	0.0001	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—MMP9—atherosclerosis	1.34e-05	9.99e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—NFKB1—atherosclerosis	1.32e-05	9.88e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—TGFB1—atherosclerosis	1.32e-05	9.88e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.32e-05	9.88e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—MAPK8—atherosclerosis	1.32e-05	9.83e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling by GPCR—AKT1—atherosclerosis	1.31e-05	9.81e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—TGFB1—atherosclerosis	1.31e-05	9.8e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—MAPK3—atherosclerosis	1.31e-05	9.8e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—PLA2G1B—atherosclerosis	1.31e-05	9.79e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—NOS3—atherosclerosis	1.3e-05	9.73e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—MAPK8—atherosclerosis	1.3e-05	9.72e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—VEGFA—atherosclerosis	1.3e-05	9.7e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling by GPCR—AKT1—atherosclerosis	1.3e-05	9.69e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.3e-05	9.68e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—MAPK3—atherosclerosis	1.29e-05	9.64e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—STAT3—atherosclerosis	1.29e-05	9.6e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.28e-05	9.59e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.28e-05	9.57e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—TGFB1—atherosclerosis	1.27e-05	9.5e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—ALOX5—atherosclerosis	1.27e-05	9.45e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—VEGFA—atherosclerosis	1.26e-05	9.43e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—TGFB1—atherosclerosis	1.25e-05	9.35e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—STAT3—atherosclerosis	1.25e-05	9.34e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—CXCL8—atherosclerosis	1.24e-05	9.28e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—MAPK3—atherosclerosis	1.23e-05	9.17e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—VEGFA—atherosclerosis	1.22e-05	9.08e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—STAT3—atherosclerosis	1.2e-05	8.99e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—VEGFA—atherosclerosis	1.2e-05	8.97e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—MAPK3—atherosclerosis	1.2e-05	8.92e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—TGFB1—atherosclerosis	1.19e-05	8.9e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—STAT3—atherosclerosis	1.19e-05	8.88e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.17e-05	8.74e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—TGFB1—atherosclerosis	1.16e-05	8.66e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—CXCL8—atherosclerosis	1.16e-05	8.63e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—MAPK3—atherosclerosis	1.15e-05	8.59e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—MAPK3—atherosclerosis	1.14e-05	8.49e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—NAMPT—atherosclerosis	1.14e-05	8.48e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.13e-05	8.43e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—LIPC—atherosclerosis	1.13e-05	8.43e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—MMP9—atherosclerosis	1.12e-05	8.4e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—APOC3—atherosclerosis	1.12e-05	8.37e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—GPCR downstream signaling—AKT1—atherosclerosis	1.12e-05	8.34e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—TGFB1—atherosclerosis	1.12e-05	8.33e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—LDLR—atherosclerosis	1.12e-05	8.32e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—NFKB1—atherosclerosis	1.11e-05	8.31e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—TGFB1—atherosclerosis	1.1e-05	8.23e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—IL6—atherosclerosis	1.1e-05	8.21e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—MAPK8—atherosclerosis	1.09e-05	8.17e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—CETP—atherosclerosis	1.09e-05	8.13e-05	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—IL6—atherosclerosis	1.08e-05	8.09e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—MMP9—atherosclerosis	1.05e-05	7.81e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—SCARB1—atherosclerosis	1.04e-05	7.79e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—NFKB1—atherosclerosis	1.03e-05	7.72e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—MAPK8—atherosclerosis	1.02e-05	7.59e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.02e-05	7.58e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling by GPCR—AKT1—atherosclerosis	1.01e-05	7.57e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—VEGFA—atherosclerosis	1.01e-05	7.54e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—STAT3—atherosclerosis	1e-05	7.47e-05	CbGpPWpGaD
Oxtriphylline—PDE4C—Signaling Pathways—AKT1—atherosclerosis	1e-05	7.47e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—IL6—atherosclerosis	9.98e-06	7.45e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Gene Expression—AKT1—atherosclerosis	9.91e-06	7.4e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—IL6—atherosclerosis	9.89e-06	7.38e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—HMGCR—atherosclerosis	9.85e-06	7.35e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—IL6—atherosclerosis	9.6e-06	7.16e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—MAPK3—atherosclerosis	9.56e-06	7.13e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—IL6—atherosclerosis	9.44e-06	7.04e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—VEGFA—atherosclerosis	9.39e-06	7.01e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—STAT3—atherosclerosis	9.3e-06	6.94e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—TGFB1—atherosclerosis	9.27e-06	6.92e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Disease—AKT1—atherosclerosis	9.2e-06	6.87e-05	CbGpPWpGaD
Oxtriphylline—ADORA2B—Signaling Pathways—AKT1—atherosclerosis	9.13e-06	6.81e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—IL6—atherosclerosis	8.98e-06	6.71e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	8.89e-06	6.63e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—MAPK3—atherosclerosis	8.88e-06	6.63e-05	CbGpPWpGaD
Oxtriphylline—PDE3B—Signaling Pathways—AKT1—atherosclerosis	8.85e-06	6.61e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—ABCA1—atherosclerosis	8.78e-06	6.55e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—IL6—atherosclerosis	8.74e-06	6.52e-05	CbGpPWpGaD
Oxtriphylline—PDE4D—Signaling Pathways—AKT1—atherosclerosis	8.71e-06	6.5e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—TGFB1—atherosclerosis	8.62e-06	6.43e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—IL6—atherosclerosis	8.41e-06	6.28e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—IL6—atherosclerosis	8.31e-06	6.2e-05	CbGpPWpGaD
Oxtriphylline—PDE4A—Signaling Pathways—AKT1—atherosclerosis	8.29e-06	6.19e-05	CbGpPWpGaD
Oxtriphylline—PDE3A—Signaling Pathways—AKT1—atherosclerosis	8.06e-06	6.02e-05	CbGpPWpGaD
Oxtriphylline—ADORA1—Signaling Pathways—AKT1—atherosclerosis	7.76e-06	5.79e-05	CbGpPWpGaD
Oxtriphylline—PDE4B—Signaling Pathways—AKT1—atherosclerosis	7.67e-06	5.72e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—HMOX1—atherosclerosis	7.53e-06	5.62e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—APOB—atherosclerosis	7.22e-06	5.39e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—GSTM1—atherosclerosis	7.02e-06	5.24e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—IL6—atherosclerosis	6.99e-06	5.21e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—LPL—atherosclerosis	6.89e-06	5.14e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—GPX1—atherosclerosis	6.72e-06	5.02e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—CD36—atherosclerosis	6.55e-06	4.89e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—IL6—atherosclerosis	6.5e-06	4.85e-05	CbGpPWpGaD
Oxtriphylline—HDAC2—Signaling Pathways—AKT1—atherosclerosis	6.45e-06	4.81e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—MTHFR—atherosclerosis	6.2e-06	4.63e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—PPARA—atherosclerosis	6.09e-06	4.54e-05	CbGpPWpGaD
Oxtriphylline—ADORA2A—Signaling Pathways—AKT1—atherosclerosis	5.99e-06	4.47e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—AGT—atherosclerosis	5.89e-06	4.4e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—APOE—atherosclerosis	5.78e-06	4.31e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—CAV1—atherosclerosis	5.72e-06	4.27e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—APOA1—atherosclerosis	5.71e-06	4.26e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—PIK3CG—atherosclerosis	5.21e-06	3.89e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—PPARG—atherosclerosis	5.03e-06	3.75e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—INS—atherosclerosis	4.93e-06	3.68e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—ALB—atherosclerosis	4.52e-06	3.38e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—NOS3—atherosclerosis	4.33e-06	3.23e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—PTGS2—atherosclerosis	3.96e-06	2.95e-05	CbGpPWpGaD
Oxtriphylline—CYP1A2—Metabolism—AKT1—atherosclerosis	1.99e-06	1.48e-05	CbGpPWpGaD
